<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00915967</url>
  </required_header>
  <id_info>
    <org_study_id>IRB_5170</org_study_id>
    <nct_id>NCT00915967</nct_id>
  </id_info>
  <brief_title>Prevention of Neurosurgical Wound Infections</brief_title>
  <acronym>POWI</acronym>
  <official_title>Pilot Project: Prevention of Neurosurgical Wound Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine whether injecting the antibiotic vancomycin directly
      into surgical wounds can decrease the rate of infection following implantation of
      neurosurgical devices.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of infection that requires removal of the neurosurgical device</measure>
    <time_frame>Six months post-operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of additional antibiotic usage beyond the standard of care</measure>
    <time_frame>Six months post-operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Surgical Wound Infections</condition>
  <arm_group>
    <arm_group_label>Vancomycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in the experimental group will receive Vancomycin injected directly into the wound pocket.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in the saline group will receive a Saline injection directly into the wound pocket.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>Subjects randomized to the vancomycin group will receive an injection (up to 10 mL) of 5 mg/mL vancomycin administered directly into the wound with a blunt needle following watertight fascial closure.</description>
    <arm_group_label>Vancomycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (Saline Solution)</intervention_name>
    <description>Subjects randomized to the saline group will receive an injection (up to 10 mL) of saline solution directly into the wound following watertight fascial closure.</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  deep brain stimulators (DBS)

          -  spinal cord stimulators (SCS)

          -  motor cortex stimulators (MCS)

          -  vagus nerve stimulators (VNS)

          -  peripheral nerve stimulators (PNS)

        Exclusion Criteria:

          -  allergies to vancomycin

          -  immunocompromise or taking immunosuppressant drugs

          -  currently taking aminoglycoside antibiotics, such as amikacin, gentamicin, neomycin,
             streptomycin or tobramycin

          -  diagnosed renal failure

          -  currently undergoing chemotherapy

          -  pregnancy

          -  non-english speakers

          -  unable to return for follow-up, or unable to be contacted by telephone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim J Burchiel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurological Surgery, Oregon Health &amp; Science University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valerie C Anderson, PhD, MCR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurological Surgery, Oregon Health &amp; Science University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen T Magill, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Medicine, Oregon Health &amp; Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Miller JP, Acar F, Burchiel KJ. Significant reduction in stereotactic and functional neurosurgical hardware infection after local neomycin/polymyxin application. J Neurosurg. 2009 Feb;110(2):247-50.</citation>
    <PMID>19263587</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2009</study_first_submitted>
  <study_first_submitted_qc>June 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2009</study_first_posted>
  <last_update_submitted>September 3, 2012</last_update_submitted>
  <last_update_submitted_qc>September 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Kim J. Burchiel</investigator_full_name>
    <investigator_title>Kim J. Burchiel, MD / John Raaf Professor and Chairman, Department of Neurological Surgery</investigator_title>
  </responsible_party>
  <keyword>Infection</keyword>
  <keyword>Vancomycin</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>Stimulator</keyword>
  <keyword>Pump</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>Intrathecal Pump</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

